Paroxetine for somatic pain associated with physical illness: a review

about

Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications.Paroxetine for patients with undifferentiated somatoform disorder: A prospective, open-label, 8-week pilot study Block of persistent late Na+ currents by antidepressant sertraline and paroxetine.

P2860

Q37225947-F8C88BEB-204D-4551-9C3D-6B96B6D20FFE Q37672705-2C12615D-0C8A-4D22-9622-36C9F753A8A1 Q39991121-73E7FD20-4F23-4DC3-BC6F-1CFA873667ED

P2860

Paroxetine for somatic pain associated with physical illness: a review

Item

http://www.wikidata.org/entity/Q36567378

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Paroxetine for somatic pain associated with physical illness: a review

@ast

Paroxetine for somatic pain associated with physical illness: a review

@en

type

Item

label

Paroxetine for somatic pain associated with physical illness: a review

@ast

Paroxetine for somatic pain associated with physical illness: a review

@en

prefLabel

Paroxetine for somatic pain associated with physical illness: a review

@ast

Paroxetine for somatic pain associated with physical illness: a review

@en

P1476

Paroxetine for somatic pain associated with physical illness: a review

@en

P2093

Ashwin A Patkar

http://www.w3.org/2001/XMLSchema#string

Meera Narasimhan

http://www.w3.org/2001/XMLSchema#string

Prakash S Masand

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence, etiology, and treatment of depression in Parkinson's disease

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

Paroxetine efficacy in the treatment of generalized anxiety disorder

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group

Comorbidity in primary care: presentation and consequences.

Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety.

Open-label treatment with citalopram in patients with irritable bowel syndrome: a pilot study.

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study.

P304

122-130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4088/PCC.V08N0301

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16912814

http://www.w3.org/2001/XMLSchema#string

P932

1540386

http://www.w3.org/2001/XMLSchema#string

Paroxetine for somatic pain associated with physical illness: a review

about

P2860

P2860

Paroxetine for somatic pain associated with physical illness: a review

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932